- Home
- DOMH vs WHWK Comparison
DOMH vs WHWK Comparison
Compare DOMH & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- WHWK
- Stock Information
- Founded
- DOMH 1967
- WHWK 2007
- Country
- DOMH United States
- WHWK United States
- Employees
- DOMH N/A
- WHWK N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- DOMH Health Care
- WHWK Health Care
- Exchange
- DOMH Nasdaq
- WHWK Nasdaq
- Market Cap
- DOMH 94.0M
- WHWK 82.4M
- IPO Year
- DOMH N/A
- WHWK N/A
- Fundamental
- Price
- DOMH $6.65
- WHWK $1.79
- Analyst Decision
- DOMH
- WHWK
- Analyst Count
- DOMH 0
- WHWK 0
- Target Price
- DOMH N/A
- WHWK N/A
- AVG Volume (30 Days)
- DOMH 363.2K
- WHWK 111.3K
- Earning Date
- DOMH 11-07-2025
- WHWK 08-07-2025
- Dividend Yield
- DOMH 8.10%
- WHWK N/A
- EPS Growth
- DOMH N/A
- WHWK N/A
- EPS
- DOMH N/A
- WHWK N/A
- Revenue
- DOMH $52,811,000.00
- WHWK $21,596,000.00
- Revenue This Year
- DOMH N/A
- WHWK N/A
- Revenue Next Year
- DOMH N/A
- WHWK N/A
- P/E Ratio
- DOMH N/A
- WHWK N/A
- Revenue Growth
- DOMH 455.38
- WHWK N/A
- 52 Week Low
- DOMH $0.83
- WHWK $1.39
- 52 Week High
- DOMH $13.58
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- DOMH 58.05
- WHWK 51.81
- Support Level
- DOMH $5.61
- WHWK $1.76
- Resistance Level
- DOMH $6.60
- WHWK $1.85
- Average True Range (ATR)
- DOMH 0.46
- WHWK 0.07
- MACD
- DOMH 0.02
- WHWK 0.01
- Stochastic Oscillator
- DOMH 70.22
- WHWK 70.37
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.